Ranked by reported Q1 2026 13F market value
Share of total reported institutional value in VTGN held by the largest 10 / 25 filers.
| # | Institution | Shares Held | Market Value | QoQ Change | Ownership % | % of Fund |
|---|---|---|---|---|---|---|
| 1 | ORBIMED ADVISORS LLC | 3.1M | $1.7M | β | 7.748% | 0.04% |
| 2 | TCG Crossover Management, LLC | 2.7M | $1.5M | 0.0% | 6.777% | 0.04% |
| 3 | VANGUARD CAPITAL MANAGEMENT LLC | 1.6M | $900K | β | 3.986% | 0.00% |
| 4 | ADAR1 Capital Management, LLC | 751K | $429K | +1.0% | 1.902% | 0.03% |
| 5 | MILLENNIUM MANAGEMENT LLC | 644K | $368K | +227.0% | 1.632% | 0.00% |
| 6 | Ikarian Capital, LLC | 519K | $297K | 0.0% | 1.314% | 0.03% |
| 7 | TWO SIGMA INVESTMENTS, LP | 470K | $268K | +140.1% | 1.189% | 0.00% |
| 8 | GEODE CAPITAL MANAGEMENT, LLC | 453K | $259K | +28.5% | 1.148% | 0.00% |
| 9 | BlackRock, Inc. | 449K | $256K | +6.1% | 1.136% | 0.00% |
| 10 | LUMINUS MANAGEMENT LLC | 396K | $226K | +13.2% | 1.003% | 0.14% |
| 11 | RENAISSANCE TECHNOLOGIES LLC | 291K | $166K | +81.2% | 0.738% | 0.00% |
| 12 | AdvisorShares Investments LLC | 277K | $158K | +10.8% | 0.702% | 0.03% |
| 13 | VANGUARD FIDUCIARY TRUST CO | 218K | $125K | β | 0.551% | 0.00% |
| 14 | Verdad Advisers, LP | 185K | $106K | β | 0.468% | 0.12% |
| 15 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | 183K | $105K | -77.8% | 0.463% | 0.00% |
| 16 | XTX Topco Ltd | 153K | $87K | β | 0.387% | 0.00% |
| 17 | Shay Capital LLC | 144K | $83K | β | 0.366% | 0.01% |
| 18 | BOOTHBAY FUND MANAGEMENT, LLC | 135K | $77K | 0.0% | 0.341% | 0.00% |
| 19 | STATE STREET CORP | 121K | $69K | 0.0% | 0.307% | 0.00% |
| 20 | TUDOR INVESTMENT CORP ET AL | 106K | $61K | +39.4% | 0.269% | 0.00% |
| 21 | DIADEMA PARTNERS LP | 105K | $60K | -48.9% | 0.267% | 0.02% |
| 22 | STEMPOINT CAPITAL LP | 617K | $58K | 0.0% | 1.562% | 0.02% |
| 23 | SIMPLEX TRADING, LLC | 90K | $51K | β | 0.227% | 0.00% |
| 24 | UBS Group AG | 79K | $45K | +51.4% | 0.199% | 0.00% |
| 25 | NORTHERN TRUST CORP | 73K | $42K | 0.0% | 0.184% | 0.00% |
denotes a marquee investor (Buffett, Burry, ARK, Tiger Global, Pershing Square, Baupost and other widely-followed managers). β% of Fundβ shows how much of that investorβs total 13F portfolio is invested in VTGN β a direct measure of their conviction.
Filings activity in VTGN during Q1 2026, grouped by how each filer changed its position.
8 quarters of 13F filings Β· Ξ columns show change vs prior quarter
| Quarter | Inst. Holders | Ξ Holders | Ownership % | Ξ Ownership | Total 13F Value | Ξ Value |
|---|---|---|---|---|---|---|
| Q1 2026 | 54 | +3.8% | 33.99% | +2.05 pp | $8M | +6.4% |
| Q4 2025 | 52 | 5.5% | 31.94% | 168.05 pp | $7M | 90% |
| Q3 2025 | 55 | +5.8% | 199.99% | +67.33 pp | $72M | +137% |
| Q2 2025 | 52 | +4.0% | 132.66% | 38.80 pp | $30M | 23% |
| Q1 2025 | 50 | 7.4% | 171.46% | 28.53 pp | $39M | 15% |
| Q4 2024 | 54 | +17% | 199.99% | +2.06 pp | $46M | +1.4% |
| Q3 2024 | 46 | +7.0% | 197.93% | 2.06 pp | $45M | 18% |
| Q2 2024 | 43 | β | 199.99% | β | $55M | β |
Source: SEC 13F institutional filings. Ownership % requires market cap data and will show once linked. Ξ columns compare to the immediately prior filed quarter.
Quick answers to the most common questions about buying VTGN stock.
Based on Q1 2026 13F filings, institutional ownership of VistaGen Therapeutics, Inc. stands at 34.0%, held across 54 reporting institutions.
ORBIMED ADVISORS LLC is the largest reported institutional holder of VTGN, with approximately 3,060,000 shares worth $0.00B as of Q1 2026.
Yes β 4 widely-followed marquee investors appear among the top 25 institutional holders of VTGN, including MILLENNIUM MANAGEMENT LLC, TWO SIGMA INVESTMENTS, LP, RENAISSANCE TECHNOLOGIES LLC, SUSQUEHANNA INTERNATIONAL GROUP, LLP.
Our composite Smart Money Score for VTGN is 72 out of 100 (Bullish). It combines net institutional buying activity, ownership shift, marquee investor presence, and holder-count growth.
18 institutions opened new positions in VTGN during Q1 2026, while 16 fully exited. 8 added to existing positions and 27 trimmed.
VTGN institutional ownership rose by 2.05 percentage points quarter-over-quarter, with a net change of +2 holders.
The top 10 institutions account for 81.2% of all reported 13F value in VTGN, and the top 25 account for 97.9%.
All data is sourced from SEC Form 13F filings, which institutional investment managers with at least $100M in assets are required to file each quarter. We process every 13F filing from EDGAR and recompute the aggregates after each cycle. Insider transactions are sourced from Form 4 filings.
VistaGen Therapeutics, Inc. (VTGN) Institutional Ownership